Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ahmed A. Refae"'
Autor:
Ezzeldin M. Ibrahim, Bushra A. Al-Quzi, Ahmed Y. Shaheen, Mohammed H. Kulak, Ahmed A. Refae, Meteb E. Al-Foheidi
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEOncotype Dx Recurrence Score (RS) is prognostic and predictive of chemotherapy benefit in women with node-negative and node-positive in hormone receptor–positive (HR+), human epidermal growth factor receptor 2–negative (HER2–) early brea
Externí odkaz:
https://doaj.org/article/67ab6bb67b9742579e1fc27d3cb0b20f
Autor:
Ahmed Anwar Refae
Publikováno v:
Annals of Agricultural Science, Moshtohor. 59:189-206
استهدف البحث التعرف على آليات برنامج الأمان الإجتماعى بالمجتمعات الصحراوية و درجة أستفادة المبحوثين منه و المعوقات التى تواجه المبحوثي
Autor:
Ezzeldin M. Ibrahim, Osama A. Al-Masri, Ahmed A. Refae, Rafat I. AbuShakra, Nasir A. Saleem, Ibrahim Mansoor, Wesal M. Eldahna, Ali M. Bayer
Publikováno v:
Annals of Clinical Oncology. :1-7
Background: Genomic tumor profiling is a novel technique that led to the identification of many genomic alterations in tumor tissues that could be exploited to deliver precise therapy to individual patient. Lack of data from Saudi Arabia about the ut
Publikováno v:
Future oncology (London, England). 16(10)
Aim: Poly(ADP-ribose) polymerase inhibitors (PARPIs) improved progression-free survival among patients with recurrent ovarian cancer. This meta-analysis examined the effectiveness of PARPIs as maintenance strategy for newly diagnosed patients with ad
Publikováno v:
Journal of Cancer Therapy. :748-758
Purpose: Radiotherapy with concurrent temozolomide (TMZ), followed by 6 cycles of adjuvant TMZ, is the standard of care for newly diagnosed Glioblastoma Mulltiforme (GBM). However tumor progression is the role with median survival of almost 14 months
Publikováno v:
Medical oncology (Northwood, London, England). 34(7)
Adjuvant endocrine therapy for 5 years is the standard adjuvant treatment for estrogen receptor-positive breast cancer while the benefits of extended adjuvant endocrine therapy (EAET) beyond 5 years are still controversial. That controversy prompted
Autor:
Ebrahim N; Department of Histology and Cell Biology, Benha University, Benha, Qalyubia 13518, Egypt. nesrien.salem@fmed.bu.edu.eg.; Stem Cell Unit, Benha University, Benha, Qalyubia 13518, Egypt. nesrien.salem@fmed.bu.edu.eg., Mandour YMH; Department of Otorhinolaryngology, Faculty of Medicine, Benha University, Benha, Qalyubia 13518, Egypt. yasser.mandour@fmed.bu.edu.eg., Farid AS; Department of Clinical Pathology, Faculty of Veterinary Medicine, Benha University, Moshtohor, Toukh, Qalyubia 13736, Egypt. ayman.samir@fvtm.bu.edu.eg., Nafie E; Zoology Department, Faculty of Science, Benha University, Benha 13518, Egypt. ebtesam.nafe@fsc.bu.edu.eg., Mohamed AZ; Department of Microbiology, Faculty of Science, Tanta University, Tanta 31527, Egypt. a.shenawy.32016@alexu.edu.eg., Safwat M; Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo 11562, Egypt. Miriam.safwat@kaseralainy.edu.eg., Taha R; Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo 11562, Egypt. radwa.taha@kaseralainy.edu.eg., Sabry D; Department of Medical Biochemistry, Faculty of Medicine, Cairo University, Cairo 11562, Egypt. dinasabry@kasralainy.edu.eg.; Molecular Biology and Stem Cell Unit, Faculty of Medicine, Cairo University, Cairo 11562, Egypt. dinasabry@kasralainy.edu.eg., Sorour SM; Department of Clinical Pharmacology, Faculty of Medicine, Benha University, Benha, Qalyubia 13518, Egypt. safwa.sorour@fmed.bu.edu.eg., Refae A; Department of Otorhinolaryngology, Faculty of Medicine, Benha University, Benha, Qalyubia 13518, Egypt. ahmed.alrefaai@fmed.bu.edu.eg.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2019 Feb 18; Vol. 20 (4). Date of Electronic Publication: 2019 Feb 18.